STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world

BACKGROUND: Mutations in STK11 (STK11m) and frequently co-occurring KRAS mutations (KRASm/STK11m) are associated with poor survival in metastatic NSCLC (mNSCLC) immuno-oncology trials. There are limited data regarding the prognostic significance of these mutations in a real-world setting. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Shire, Norah J., Klein, Alyssa B., Golozar, Asieh, Collins, Jenna M., Fraeman, Kathy H., Nordstrom, Beth L., McEwen, Robert, Hembrough, Todd, Rizvi, Naiyer A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470384/
https://www.ncbi.nlm.nih.gov/pubmed/32881920
http://dx.doi.org/10.1371/journal.pone.0238358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470384/
https://www.ncbi.nlm.nih.gov/pubmed/32881920
http://dx.doi.org/10.1371/journal.pone.0238358

Ejemplares similares